Granisetron plus aprepitant versus granisetron in preventing nausea and vomiting during CHOP or R-CHOP regimen in malignant lymphoma: a retrospective study

机译：Granisetron联合阿瑞匹坦与Granisetron预防恶性淋巴瘤CHOP或R-CHOP方案期间的恶心和呕吐：一项回顾性研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Patient backgrounds treated with CHOP or R-CHOP regimen in malignant lymphoma with or without aprepitant

机译：在有或没有阿瑞匹坦的恶性淋巴瘤中使用CHOP或R-CHOP方案治疗的患者背景

著录项

期刊名称 Journal of Pharmaceutical Health Care and Sciences
作者
Yoshinori Wakasugi; Satoshi Noda; Yoshihiro Ikuno; Miya Horie; Katsuyuki Kito; Hitoshi Minamiguchi; Tomohiro Terada;
展开▼
作者单位

展开▼
年(卷),期 2019(5),-1
年度 2019
页码 -1
总页数 5
原文格式 PDF
正文语种
中图分类药学;
关键词
Aprepitant; Granisetron; CHOP; Complete response; Complete protection;

机译：阿瑞匹坦;格兰尼司琼;CHOP;完全反应;完全保护;
入库时间 2022-08-21 11:42:09

相似文献

外文文献
中文文献
专利

1. Granisetron plus aprepitant versus granisetron in preventing nausea and vomiting during CHOP or R-CHOP regimen in malignant lymphoma: a retrospective study [J] . Yoshinori Wakasugi, Satoshi Noda, Yoshihiro Ikuno, Journal of Pharmaceutical Health Care and Sciences . 2019,第1期

机译：Granisetron加上试剂与Granisetron在防止恶魔和恶性淋巴瘤中的R-Choc方案期间预防恶心和呕吐：回顾性研究
2. Randomized, double-blind, phase III trial of palonosetron versus granisetron in the triplet regimen for preventing chemotherapy-induced nausea and vomiting after highly emetogenic chemotherapy: TRIPLE study [J] . Suzuki K., Yamanaka T., Hashimoto H., Annals of oncology: official journal of the European Society for Medical Oncology . 2016,第8期

机译：帕洛诺司琼与格拉司琼三重方案预防高致呕性化疗后化疗引起的恶心和呕吐的随机，双盲，III期试验：TRIPLE研究
3. Efficacy and safety of 5 mg olanzapine combined with aprepitant, granisetron and dexamethasone to prevent carboplatin-induced nausea and vomiting in patients with gynecologic cancer: A multi-institution phase II study [J] . Iihara Hirotoshi, Shimokawa Mototsugu, Hayasaki Yoh, Gynecologic Oncology: An International Journal . 2020,第3期

机译：5毫克奥氮藻的功效和安全性联合用于治疗妇科癌症患者的卡铂诱导的恶心，呕吐：多机构期间II研究
4. Economic analysis of palonosetron versus granisetron in the standard triplet regimen for preventing chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy in Japan (TRIPLE phase III trial) [O] . Hisanori Shimizu, Kenichi Suzuki, Takeshi Uchikura, 2018

机译：在日本接受高呕吐化疗的标准三联体方案中预防帕洛诺司琼与格拉司琼的经济分析以防止化疗引起的恶心和呕吐（TRIPLE III期试验）
5. Phase 3 efficacy results of a single dose of NEPA, a fixed combination of netupitant and palonosetron, versus a 3-day regimen of aprepitant/granisetron (APR/GRAN) for prevention of chemotherapy-induced nausea and vomiting (CINV) in Chinese patients [O] . L. Zhang, S. Lu, A. Dechaphunkul, 2017

机译：单剂量NEPA的疗效结果，Netupitant和Palonosetron的固定组合，与用于预防中国患者的化疗诱导的化疗诱导的恶心和呕吐（CINV）的3天的3天

Granisetron plus aprepitant versus granisetron in preventing nausea and vomiting during CHOP or R-CHOP regimen in malignant lymphoma: a retrospective study

摘要

著录项

相似文献

相关主题

期刊订阅